Selected Faculty Publications
Below are selected publications of faculty in the Division of Infectious Diseases:
Skolnik PR, Rabbi MF, Mathys J-M, Greenberg AS.
Stimulation of peroxisome proliferator-activated receptors α and γ (PPARα and γ) blocks HIV-1 replication and TNFα production in acutely-infected primary blood cells, chronically-infected U1 cells, and alveolar macrophages from HIV-infected subjects.
JAIDS. 31:1-10, 2002.
Rostasy K, Gorgun G, Kleyner Y, Garcia A, Kramer M, Melanson SM, Mathys JM, Yiannoutsos C, Skolnik PR, Navia BA.
TNFα leads to increased cell surface expression of CXCR4 in SK N MC cells.
J Neurovirol. 11(3):247-255, 2005.
Greenwald J, Bessega S, Maeda JL, Posner M, Rich C, Skolnik PR.
Evaluation of the Centers for Disease Control and Prevention’s recommendations regarding routine testing for human immunodeficiency virus by an inpatient service: Who are we missing?
Mayo Clinic Proceedings. 81(4):452-458, 2006.
Hardy H, Stanic A, Schoonmaker C, Keyes M, Traxler T, Hall J, Skolnik P.
Monitoring adherence to antiretroviral therapy using a composite adherence score: A pilot program.
NIMH/International Association of Physicians in AIDS Care International Conference on HIV Treatment Adherence, Jersey City, NJ, March 8-10, 2006 (abstract/poster P-237).
Gulick R, Su Z, Flexner C, Hughes M, Skolnik P, Godfrey C, Greaves W, Wilkin T, Gross R, Coakley E, Zolopa A, Hirsch M, Kuritzkes D, for the ACTG 5211 Study Team.
ACTG 5211: Phase II study of the safety and efficacy of vicriviroc in HIV-infected treatment-experienced subjects.
XVI International AIDS Conference, Toronto, Canada, August 2006 (late breaker abstract THLB0217).
Nicol M, Pereira A, Mathys J-M, Skolnik PR.
Altered TLR-dependent innate immune responses in the lung during HIV 1 infection.
14th Conference on Retroviruses and Opportunistic Infections (CROI 2007), Los Angeles, CA, Feb 25-28, 2007 (abstract A-149).
Barlam TF.
The impact of antibiotic use in agriculture on human health and the appropriate public policy response. In: Kleinman DL, Abby J, Kinchy AJ, Handelsman J, eds.
Controversies in Science and Technology, Volume 1: From Maize to Menopause. Madison, WI: University of Wisconsin Press January. 2005.
Barlam T, DiVall M.
Antibiotic Stewardship Practices at Top Academic Centers Throughout the United States and at Hospitals Throughout Massachusetts.
Infection Control and Hospital Epidemiology. 27(7): 695-703, 2006.
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg MD, Boardman KD, Willams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachuki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh S-S, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan ISF, Wang WWB, Annunziato PW, and Silber JL for the Shingles Prevention Study Group.
Varicella-Zoster Vaccine to Prevent Herpes Zoster.
N Engl J Med. 352: 2271-84, 2005.
Keenan JF, Cahill LS, Fuller JD, Kelly KA (editors).
Catholic Ethicists on HIV/AIDS Prevention.
Continuum (New York), 2000.
Fuller J.
On ‘Straightening Out’ Catholic Seminaries.
America. Vol 187, No. 20, 7-9, December 16, 2002.
Fuller JD, SJ, and Keenan JF, SJ.
“Church Politics and HIV Prevention: Why is the Condom Question So Significant and So Neuralgic?”
Between Poetry and Politics, Essays in Honour of Enda McDonagh. Linda Hogan and Barbara FitzGerald (eds.).
The Columba Press, Dublin.158-181, 2003.
Boswell SL and Fuller JD.
Pathogenesis and Natural History.
HIV (Howard Libman and Harvey J Makadon, eds.), Second Edition.
American College of Physicians – American Society of Internal Medicine, Philadelphia. 16-38, 2003.
Fuller JD and Keenan JF.
The Language of Human Rights and Social Justice in the Face of HIV/AIDS.
Budhi (the Philippines). (1&2):211-231, 2004.
Fuller J and Keenan J.
Condoms and Chastity.
The Tablet (United Kingdom). 18, July 24, 2004.
Fuller J and Keenan JF.
The International AIDS Conference in Bangkok: Two Views.
America. Vol 191, No. 5, August 30 – September 6, 2004.
Fuller J, SJ and Keenan J, SJ.
“Educating in a Time of HIV/AIDS,” Opening Up: Speaking Out in the Church.
Julian Filochowski and Peter Stanford (eds.), Darton, Longman and Todd Ltd., London. 95-113, 2005.
Fuller JD.
“Whose Life? The Clinical Experience.”
One of four essays on the Terry Schiavo Case
Published in Boston College Magazine, Spring. 44-45, 2005.
Fuller J.
Developing admissions policies regarding HIV.
Horizon (Journal of the National Religious Vocation Conference). 31(2):20-27, 2006.
Ganley-Leal LM, Liu XP and Wetzler LM.
Toll-like receptor 2-mediated human B cell differentiation.
Clin Immunol. 120:272-84, 2006.
Chae P, Im M, Gibson F, Jiang Y, Graves DT.
Mice lacking monocyte chemoattractant protein 1 have enhanced susceptibility to an interstitial polymicrobial infection due to impaired monocyte recruitment.
Infect Immun. 2002. 70(6):3164-9.
Nassar H, Chou HH, Khlgatian M, Gibson FC III, Van Dyke TE, Genco CA.
Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells.
Infect Immun. 2002. 70(1):268-76.
Gonzalez D, Tzianabos AO, Genco CA, Gibson FC III.
Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model.
Infect Immun. 2003. 71(4):2283-7.
Gyurko R, Boustany G, Huang PL, Kantarci A, Van Dyke TE, Genco CA, Gibson FC III.
Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis.
Infect Immun. 2003 Sep;71(9):4917-24.
Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E, Wong J, Genco CA.
Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
Circulation. 2004. 109(22):2801-6.
Gibson FC III, Savelli J, Van Dyke TE, Genco CA.
Gingipain-specific IgG in the sera of patients with periodontal disease is necessary for opsonophagocytosis of Porphyromonas gingivalis.
J Periodontol. 2005. 76(10):1629-36.
Takahashi Y, Davey M, Yumoto H, Gibson FC III, Genco CA.
Fimbria-dependent activation of pro-inflammatory molecules in Porphyromonas gingivalis infected human aortic endothelial cells.
Cell Microbiol. 2006. 8(5):738-57.
d’Empaire G, Baer MT, Gibson FC III.
The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.
Infect Immun. 2006. 74(11):6236-43.
Hamer DH, MacLeod W, Addo-Yobo E, Duggan CP, Estrella B, Fawzi WW, Konde-Lule JK, Mwanakasale V, Premji ZG, Sempértegui F, Simon JL, Ssengooba FP, Yeboah-Antwi K, and the ZAP (Zinc Against Plasmodium) Study Group.
Age, temperature, and parasite density predict chloroquine treatment failure in children with uncomplicated falciparum malaria.
Trans R Soc Trop Med Hyg. 97:422-28, 2003.
Hamer DH, Connor B.
Travel health knowledge, attitudes and practices among United States travelers.
J Travel Med. 11:23-26, 2004.
Gill CJ, Sabin LL, Tham J, Hamer DH.
Reconsidering cotrimoxazole prophylaxis for HIV-exposed African infants.
WHO Bulletin. 82:1-7, 2004.
Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, Hamer DH.
Vitamin E and respiratory infections among elderly nursing home residents: a randomized controlled trial.
JAMA. 292:828-836, 2004.
Duggan CP, MacLeod WB, Krebs NF, Westcott JL, Fawzi WW, Premji ZG, Mwanakasale M, Simon JL, Yeboah-Antwi K, Hamer DH and the Zinc Against Plasmodium Study Group.
Plasma zinc concentrations are depressed during the acute phase response in children with falciparum malaria.
J Nutr. 135:802-7, 2005.
Fox M, Lash T, Hamer DH.
A sensitivity analysis of a randomized controlled trial of zinc in treatment of falciparum malaria in children.
Contemporary Clin Trials. 26:281-9, 2005.
Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin L.
No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa.
AIDS. 19:1243-9, 2005.
Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW.
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross-sectional study.
Brit Med J. 331:734-7, 2005.
Rodríguez A, Hamer DH, Rivera J, Acosta M, Salgado G, Gordillo M, Cabezas M, Naranjo C, Leguísamo J, Gómez D, Fuenmayor G, Játiva E, Guamán G, Estrella B, Sempértegui F.
Effects of moderate doses of vitamin A as an adjunct to the treatment of pneumonia in underweight and normal children: a randomized, double-blind, placebo controlled trial.
Am J Clin Nutr. 82:1090-6, 2005.
Saha SK, Darmstadt GL, Yamanaka N, Billal DS, Nasreen T, Islam M, Hamer DH.
Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden.
Pediatr Infect Dis J. 24:1093-1098, 2005.
Lee ES, Zhou H, Henderson AJ.
Endothelial cells induce HIV-1 expression by activating C/EBP b.
J. Virol. 75: 9703-9712, 2001.
Lee ES, Sarma D, Zhou H, Henderson AJ.
CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long terminal repeat in monocytic cells.
Virology. 299:20-31, 2002.
Cook JA, August A, Henderson AJ.
CD28-dependent activation of phosphatidylinositol 3-kinase inhibits HIV-1 transcription by regulating Tat transcriptional transactivation.
J. Immunol. 169:254-260, 2002.
Cook JA, Albacker L, August A, Henderson AJ.
CD28-dependent HIV-1 transcription is associated with Vav, Rac1 and NF- k B activation.
J. Biol. Chem. 278: 35812-35818, 2003.
Callahan MK, Popernack P, Tsutsui S, Truong L, Schlegel RA, Henderson AJ.
Role of phosphatidylserine in HIV-1 infection of macrophages.
J. Immunol. 170:4840-4845, 2003.
Lee ES, Kalantari P, Tsutsui S, Klatt A, Holden J, Correll PH, Power C, Henderson AJ.
The receptor tyrosine kinase RON, a negative regulator of inflammation, inhibits HIV transcription and is decreased in brains of AIDS patients.
J. Immunol. 173:6864-6872, 2004.
Yang P, Henderson, AJ.
Nef targets Cbl for hyper-phosphorylation in HIV-1 infected T cells.
Virology. 336:219-228, 2005.
Gekonge BN, Schiralli GM, Schlegel RA, Henderson AJ.
Apoptotic cells inhibit HIV transcription in monocytic cells by an ELMO-dependent mechanism.
J. Leuk. Biol. 80:953-960, 2006.
Benator D, Bhattacharya M, Bozeman L, Burman W, Cantazaro A, Chaisson R, Gordin F, Horsburgh CR, Horton J, Khan A, Lahart C, Metchock B, Pachucki C, Stanton L, Vernon A, Villarino ME, Wang YC, Weiner M, Weis S and the Tuberculosis Trials Consortium.
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Lancet. 360:528-34, 2002.
Leonard MK, Larsen N, Drechsler H, Horsburgh CR, et al.
Increased survival of persons with tuberculosis and human immunodeficiency virus infection, 1991-2000.
Clin Infect Dis. 34: 1002-7, 2002.
Fisk T, Hon H-M, Lennox JL, von Reyn CF, Horsburgh CR.
Testing strategy for latent tuberculosis infection among HIV-infected persons after initiation of highly active antiretroviral therapy.
AIDS. 17:1102-4, 2003.
Ellerbrock TV, Chamblee S, Bush TJ, Johnson JW, Marsh BJ, Lowell P, Trenschel RJ, von Reyn CF, Scoles L, Horsburgh CR.
HIV Infection in a Rural Community in the United States.
Am J Epidemiol. 160:582-8, 2004.
Horsburgh CR.
Prioritizing treatment of latent tuberculosis infection in the United States.
N Engl J Med. 350:260-7, 2004.
Mtei L, Matee M, Herfort O, Bakari M, Horsburgh CR, Waddell R, Cole BF, Vuola JM, Tvaroha S, Kreisworth B, Pallangyo K, von Reyn CF.
High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania.
Clin Infect Dis. 40:1500-7, 2005.
Reed C, von Reyn CF, Chamblee S, Ellerbrock TV, Johnson JW, Marsh BJ, Lowell P, Trenschel RJ, Scoles L, Horsburgh CR.
Environmental risk factors for infection with Mycobacterium avium complex.
Am J Epidemiol. 164:32-40, 2006.
Solages A, Vita JA, Thornton DJ, Murray J, Heeren T, Craven DE, Horsburgh CR.
Endothelial function in HIV-infected persons.
Clin Infect Dis. 42:1325-32, 2006.
Sterling TR, Bethel, J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, TBESC.
The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.
Am J Respir Crit Care Med. 173:927-31, 2006.
Khan A, Sterling T, Reves R, Vernon A, Horsburgh CR and the TB Trials Consortium.
Lack of weight gain and relapse risk in a large tuberculosis treatment trial.
Am J Respir Crit Care Med. 174:344-8, 2006.
Ingalls RR, Lien E, Golenbock DT.
Membrane-associated proteins of a lipopolysaccharide-deficient mutant of Neisseria meningitidis activate the inflammatory response through Toll-like receptor 2.
Infect Immun. 69:2230-6, 2001.
Lien E, Ingalls RR.
Toll-like receptors.
Crit Care Med. 30:S1-11, 2002.
Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls RR.
Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of Toll-like receptor 4-mediated signaling.
J Immunol. 168:2424-32, 2002.
Fisette PL, Ram S, Andersen JM, Guo W, Ingalls RR.
The lip lipoprotein from Neisseria gonorrhoeae stimulates cytokine release and NF-B activation in epithelial cells in a TLR2-dependent manner.
J Biol Chem. 278:46252-60, 2003.
O’Connell CM, Ionova IA, Quayle AJ, Visintin A, Ingalls RR.
Localization of TLR2 and MyD88 to C. trachomatis inclusions: Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen.
J Biol Chem. 281:1652-9, 2006.
Andersen JMA., Al-Khairy D, Ingalls RR.
Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Biol Reprod. 74:824-31, 2006.
Madico G, Quinn TC, and Gaydos CA.
Touchdown enzyme time release polymerase chain reaction (TETR-PCR) for the detection and identification of C. pneumoniae, C. trachomatis and C. psittaci using the 16S rRNA and 16S-23S spacer rRNA genes.
Journal of Clinical Microbiology. 38:1085-1093, 2000.
Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, and Ebstein SE.
Atherosclerosis in ApoE knockout mice infected with multiple pathogens.
Journal of Infectious Diseases. 183:226-231, 2001.
Rothstein NM, Quinn TC, Madico G, Gaydos CA, and Lowenstein CJ.
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
Journal of Infectious Diseases. 183:232-238, 2001.
Rompalo AM, Gaydos CA, Shah N, Tennant M, Crotchfelt KA, Madico G, Quinn TC, Daniel R, Shah KV, Gaydos JC, and McKee KT Jr.
Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women.
Clinical Infectious Diseases. 33:1455-61, 2001.
Rothman RE, Majmudar MD, Kelen GD, Madico G, Gaydos CA, Walker T, and Quinn TC.
Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated PCR Assay.
Journal of Infectious Diseases. 186:1677-81, 2002.
Rice PA, Madico GE.
Polymerase chain reaction to diagnose infective endocarditis: will it replace blood cultures?
Circulation. 111:1352-4, 2005.
Madico G, Welsch JA, Ngampasutadol J, Lewis LA, McNaughton A, Perlman D, Granoff D, Vogel U, and Ram S.
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
Journal of Immunology. 177:501-510, 2006.
Massari P, Ho Y and Wetzler LM.
Neisseria meningitidis porin PorB interacts with mitochondria and protects from apoptosis.
PNAS. 97: 9070-9075, 2000.
Massari P and Wetzler LM.
Effect of neisserial porins on host immune response.
Review, EOS Rivista di Immunologia ed Immunoterapia. 2, XX, 2000.
Massari P and Wetzler LM.
A Meningococcal Disease Protocol.
A.J.Pollard and M.C.J. Maiden eds., series Methods in molecular Medicine, Prof. J. Walker Ed.
The Humana Press, 2001.
Massari P, Henneke P, Ho Y, Latz E, Golenbock DT and Wetzler LM.
Immune stimulation by neisserial porins is TLR2 and MyD88-dependent.
J. Immunol. 168: 1533-1537, 2002.
Massari P, King CA, Ho AY, and Wetzler LM.
Neisserial PorB is translocated in the mitochondria of HeLa cells infected with N. meningitidis and protects cells from apoptosis.
Cell Microbiol. 5(2):99-109, Feb 2003.
Massari P, Ram S, Macload H and Wetzler LM.
Role of neisserial porins in bacterial pathogenesis and immunity.
Trends Microbiol. 11(2):87-93, Feb 2003.
Tan WZ, Massari P, Wetzler LM, Colombini M.
Bacterial channel inhibits apoptosis by permeabilizing the mitochondrial outer membrane.
BIOPHYSICAL JOURNAL. 86 (1): 517A-517A Part 2 Suppl. S JAN 2004.
Singleton TE, Massari P and Wetzler LM.
Neisserial porin-induced dendritic cell activation is MyD88 and TLR2-dependent.
J Immunol. 174(6):3545-50, 15 Mar 2005.
Massari P, King CA, MacLeod H and Wetzler LM.
Improved purification of native meningococcal porin PorB and studies on its structure/function.
Protein Expression and Purification. 44(2): 136-46, Dec 2005.
Massari P, Visintin A, Gunawardana J, Halmen KA, King CA, Golenbock DT and Wetzler LM.
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling.
J Immunol. 176(4):2373-80, 15 Feb 2006.
Montano MA, Novitsky VA, Blackard JT, Cho NJ, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding HIV-1 subtypes.
Journal of Virology. 71(11), 8657-8665, 1997.
Montano MA, Russell MS, Gilbert P, Thior I, Lockman S, Shapiro R, Chang SY, Lee TH, Essex M.
Comparative Prediction of Perinatal HIV-1 Transmission Using Multiple Viral Load Markers.
Journal of Infectious Diseases. 188(3), 405-413, 2003.
Montano MA, Rarick M, Sebastiani P, Brinkmann P, Skefos J, Ericksen R.
Genome-wide profiling of HIV-1 dependent cellular transcription upon exposure to N. gonorrhoeae, in vitro.
International Immunology. 18(1):125-37, Jan 2006.
Montano M, Rarick M, Sebastiani P, M Thior I, Navis A, Essex.
Gene expression profiling of HIV-1 infection and perinatal transmission in Botswana.
Genes and Immunity. 7(4):298-309, Jun 2006.
Serrao RA, Morgan MA, Daar ES, Murthy RA.
Penicillin-nonsusceptible Streptococcus pneumoniae: Epidemiology and Outcomes of Initial Antibiotic Therapy in Community-Acquired Pneumonia.
Infection Control and Hospital Epidemiology (SHEA). 20(4): 284, 1999.
Orlander J, Serrao R.
Gatifloxacin-Induced Hyperglycemia.
Infectious Diseases in Clinical Practice. 12(4): 230-232, 2004.
M.N. Oxman and the Shingles Prevention Study Group (Serrao R).
A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults.
New England Journal of Medicine. 352(22): 2271-2284, 2005.
Wetzler LM.
The role of Toll-like receptor 2 in microbial disease and immunity.
Vaccine. 21: 2:S55-60, 2003.
Wetzler LM, Guttormsen H-K.
B Lymphocyte Activation and Antibody Production, In Immunology.
Infection and Immunity, eds. G Pier, J Lyzack, LM Wetzler.
ASM Press. 233-258, 2004.
Simpson SD, Wetzler LM.
Mucosal Immunity, In Immunology.
Infection and Immunity, eds. G Pier, J Lyzack, LM Wetzler. ASM Press. 399-423, 2004.
Wetzler LM.
Antigen Processing and Presentation, In Immunology.
Infection and Immunity, eds. G. Pier, J. Lyzack, L.M. Wetzler. ASM Press, pp. 283-294, 2004.
Tzianabos A. and Wetzler LM.
Cellular Communication and Cytokines, In Immunology.
Infection and Immunity, eds. G Pier, J Lyzack, LM Wetzler, ASM Press, pp. 343-369, 2004.
Munford R, Stephens D and Wetzler LM.
Chapter 127, Meningococcal Infections.
Harrison’s Principles of Internal Medicine, 16th ed., Kasper D, et al, 2004.
Singleton T, Massari P, and Wetzler LM.
Neisserial Porin-Induced Dendritic Cell Activation is MyD88 and TLR2-dependent.
Journal of Immunology. 174(6):3545-50, 2005.
Massari P, King CA, Macleod H, and Wetzler LM.
Improved purification of native meningococcal porin PorB and studies on its structure/function.
Protein Expr. Purif. 44:136-146, 2005.
Massari P, Visintin A, Gunawardana J, Halmen K, King CA, Golenbock DT, and Wetzler LM.
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling.
J. Immunol. 176:2373-80, 2006.
Ganley-Leal LM, Liu XP and Wetzler LM.
Toll-like receptor 2-mediated human B cell differentiation.
Clin Immunol. 120:272-84, 2006.
Schnitzler AC, Burke JM and Wetzler LM.
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.
Infect Immun. 75:3150-3159, 2007.
Burke JM, Ganley-Leal LM, Khatri A and Wetzler LM.
Neisseria meningitidis PorB, a TOLL-like receptor 2 ligand, induces an antigen-specific eosinophil recall response: Potential adjuvant for helminth vaccines?
J. Immuno. 179:3222-30, 2007.
Macleod HM and Wetzler LM.
T cell activation by TLRs: a role for TLRs in the adaptive immune response.
Sci STKE. 2007(402):pe48, 2007.
Chiavolini D, Allroy J, King CA, Jorth P, Weir S, Madico G, Murphy J and Wetzler LM.
Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.
Infect Immun. 76:486-96, 2008.
Liu X, Wetzler LM and Massari P.
The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.
Vaccine. 26:786-96, 2008.
Macleod HM, Bhasin N and Wetzler LM.
Role of protein tyrosine kinase and Erk1/2 activities in the Toll-like receptor 2-induced cellular activation of murine B cells by neisserial porin.
Clin Vaccine Immunol. 15:630-7, 2008.
Chiavolini D, Weir S, Murphy JR and Wetzler LM.
Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
Clin Vaccine Immunol. 15(9):1322-9, 2008.
Shen L, Shi Y, Douglas AL, Hatch TP, O’Connell CM, Chen JM, Zhang Y-X.
Identification and characterization of promoters regulating tuf expression in Chlamydia.
Arch. Biochem. Biophys. 379:46-56, 2001.
